Re: Impact of Circulating Tumor DNA and Copy-number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated with Salvage High-dose Chemotherapy: BLOG TITLE: Value of ctDNA in Advanced Germ Cell Tumors
Re: Impact of Circulating Tumor DNA and Copy-number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated with Salvage High-dose Chemotherapy: BLOG TITLE: Value of ctDNA in Advanced Germ Cell Tumors. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826021731?dgcid=rss_sd_all
Re: Impact of Circulating Tumor DNA and Copy-number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated with Salvage High-dose Chemotherapy: BLOG TITLE: Value of ctDNA in Advanced Germ Cell Tumors. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826021731?dgcid=rss_sd_all
“Re: Impact of Circulating Tumor DNA and Copy-number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated with Salvage High-dose Chemotherapy: BLOG TITLE: Value of ctDNA in Advanced Germ Cell Tumors.” European Urology.
@article{article116733,
title = {Re: Impact of Circulating Tumor DNA and Copy-number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated with Salvage High-dose Chemotherapy: BLOG TITLE: Value of ctDNA in Advanced Germ Cell Tumors},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826021731?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...